ReviewFrontiers in oncology2024

A review of perioperative treatment strategies with immunotherapy and tyrosine kinase inhibitors in resectable and stage IIIA-N2 non-small cell lung cancer.

Madeleine B Hopson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.